• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction.

作者信息

Loo M H, Egan D, Vaughan E D, Marion D, Felsen D, Weisman S

出版信息

J Urol. 1987 Mar;137(3):571-6. doi: 10.1016/s0022-5347(17)44108-5.

DOI:10.1016/s0022-5347(17)44108-5
PMID:3820396
Abstract

A marked decrease in renal blood flow (RBF) and glomerular filtration rate (GFR) was found after 24, 48 and 72 hours of total unilateral ureteral obstruction (UUO) in the rabbit. Contralateral GFR showed a modest increase consistent with compensatory hypertrophy. The urinary excretion of thromboxane B2 (TxB2), the stable metabolite of the vasoconstrictor prostaglandin, thromboxane A2 (TxA2) was significantly elevated in the urine obtained following release of the obstructed ureter when compared to the TxB2 level in the urine from the contralateral kidney. Continuous infusion of OKY-046 at 100 micrograms./kg./min. over 24 hours during UUO decreased TxB2 excretion by greater than 80 per cent. However there was no significant preservation of RBF or GFR of the obstructed kidney following ureteral release despite the selective inhibition of TxA2. Moreover the increase in contralateral GFR was also abolished. Taken together with other studies these results strongly suggest that the potent vasoconstrictor TxA2 is not responsible for the rise in renal resistance that follows acute UUO.

摘要

相似文献

1
The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction.
J Urol. 1987 Mar;137(3):571-6. doi: 10.1016/s0022-5347(17)44108-5.
2
Effect of thromboxane inhibition on renal blood flow in dogs with complete unilateral ureteral obstruction.血栓素抑制对完全性单侧输尿管梗阻犬肾血流量的影响。
J Urol. 1986 Dec;136(6):1343-7. doi: 10.1016/s0022-5347(17)45334-1.
3
Prior inhibition of vasoconstrictors normalizes GFR in postobstructed kidneys.预先抑制血管收缩剂可使梗阻后肾脏的肾小球滤过率恢复正常。
Kidney Int. 1989 Jun;35(6):1305-14. doi: 10.1038/ki.1989.127.
4
Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.血栓素A2合成酶抑制剂OKY-046对肾脏的影响
Experientia. 1986 Jun 15;42(6):613-5. doi: 10.1007/BF01955558.
5
Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.大鼠肾毒性血清肾炎中肾小球前列腺素和血栓素的合成。对肾血流动力学的影响。
J Clin Invest. 1983 Oct;72(4):1439-48. doi: 10.1172/JCI111100.
6
Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.血栓素合成酶抑制剂OKY 046对非氮质血症性肝硬化腹水患者肾功能的影响。
Gastroenterology. 1988 Jun;94(6):1470-7. doi: 10.1016/0016-5085(88)90688-9.
7
Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction.血小板活化因子在正常大鼠及双侧输尿管梗阻大鼠肾功能中的作用。
Proc Soc Exp Biol Med. 1991 Oct;198(1):572-8. doi: 10.3181/00379727-198-43291.
8
Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.选择性血栓素合成酶抑制剂OKY-046对自发性高血压大鼠血压及血栓素合成的影响。
Prostaglandins Leukot Essent Fatty Acids. 1989 Sep;37(3):139-44. doi: 10.1016/0952-3278(89)90076-8.
9
[Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].[选择性血栓素A2合成酶抑制剂OKY-046对大鼠脊髓损伤后血栓素B2生成及血管损伤的有益作用]
Nihon Seikeigeka Gakkai Zasshi. 1990 Jan;64(1):82-8.
10
Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.血小板活化因子和血栓素A2在单侧输尿管梗阻肾脏反应中的作用。
J Urol. 1990 Jul;144(1):141-5. doi: 10.1016/s0022-5347(17)39397-7.

引用本文的文献

1
Cinnamic Acid Derivatives: Recent Discoveries and Development Strategies for Alzheimer's Disease.肉桂酸衍生物:阿尔茨海默病的最新发现与发展策略
Mini Rev Med Chem. 2025;25(2):163-175. doi: 10.2174/0113895575330648240819112435.
2
The Present and the Future of Medical Therapies for Adenomyosis: A Narrative Review.子宫腺肌病医学治疗的现状与未来:一项叙述性综述
J Clin Med. 2023 Sep 22;12(19):6130. doi: 10.3390/jcm12196130.
3
Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis.梗阻性肾病与肾间质纤维化的分子病理生理学
Physiol Rev. 2023 Oct 1;103(4):2827-2872. doi: 10.1152/physrev.00027.2022. Epub 2023 Jul 13.
4
Efficient access to aliphatic esters by photocatalyzed alkoxycarbonylation of alkenes with alkyloxalyl chlorides.通过光催化烯与烷氧基草酰氯的烷氧基羰基化反应高效获得脂肪酯。
Nat Commun. 2021 Sep 7;12(1):5328. doi: 10.1038/s41467-021-25628-x.
5
Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease.体内工程化唾液酸化致病性抗体可减轻自身免疫性疾病。
Cell. 2018 Jan 25;172(3):564-577.e13. doi: 10.1016/j.cell.2017.11.041. Epub 2017 Dec 21.
6
Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence.抗血小板治疗在子宫腺肌病治疗中具有前景:实验证据。
Reprod Biol Endocrinol. 2016 Oct 10;14(1):66. doi: 10.1186/s12958-016-0198-1.
7
Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection.血栓素A2在远程后肢预处理诱导的心脏保护中的可能作用。
Naunyn Schmiedebergs Arch Pharmacol. 2016 Jan;389(1):1-9. doi: 10.1007/s00210-015-1186-2. Epub 2015 Nov 3.
8
Syndrome de levée d'obstacle : physiopathologie et prise en charge.障碍解除综合征:病理生理学与治疗
Can Urol Assoc J. 2012 Dec;6(6):E213-6. doi: 10.5489/cuaj.11007.
9
Renal haemodynamics and prostaglandin synthesis in partial unilateral ureteric obstruction.单侧输尿管部分梗阻时的肾脏血流动力学与前列腺素合成
Urol Res. 1994;22(5):279-85. doi: 10.1007/BF00297195.